drugset / Trial / NCT03941535

Comparison of Vitamin K Doses in Patients With Larger Burn Injuries

NCT03941535

Phase 4 Unknown 50 enrolled Joseph M. Still Research Foundation, Inc.
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The use of Vitamin K in treating bleeding diatheses is well documented and accepted as standard of care, as is the effect of Vitamin K on calcium and bone metabolism. In the treatment of larger burns however, there is a paucity of available literature related to optimal daily dosing, goals of therapy and potential complications. This study aims to identify any potential issues arising from the administration of a standard of care dose in an historical cohort of subjects with larger burns to a prospective patient population given a decreasing dose during their intensive care unit (ICU) stay.

Timeline

Start
2019-05-10
Primary completion
2022-10
Completion
2022-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Vitamin K Unknown 2 mg Intravenous
Subject Vitamin K Unknown 10 mg Intravenous

Indications

No indication recorded.